Tech & Pharma
Singapore’s second satellite, built by Nanyang Technological University students, blasted off to space on board Russia’s RS-20B rocket.
Researchers and clinicians in Australia are leading a clinical trial to test a GPS-like device that tracks the position of the prostate as it moves during radiotherapy.
A Japanese-Singapore collaboration will focus on the R&D and commercialization of novel clinical approaches for diseases relevant to the Asian population.
Takeda has initiated enrollment of patients in Japan in an ongoing global Phase III clinical study of its novel oral proteasome inhibitor MLN9708.
Mallinckrodt Pharmaceuticals has partnered with China Resources Pharma to promote its Optiray™ (ioversol injection) x-ray contrast media in China.
Medifocus has entered into a joint venture agreement with Ideal Concept Group to sell and market its Prolieve treatment in China and other Asian countries.
Merck has invested €80 million into a new pharmaceutical manufacturing facility to be located in the Greater Shanghai region, China.
Eli Lilly and Company will invest US$350 million to expand its insulin cartridge manufacturing capacity in China.
Oxford Global’s Pharmaceutical IT Asia Congress will take place from March 25-26, 2014 in Singapore..
The Vietnam Ministry of Health has signed an agreement with Quintiles to enhance clinical research in Vietnam’s growing nation of 90 million people.